Home
>
National Drug Code (NDC)
>
Uroxatral
Uroxatral - 24987-200-20 - (alfuzosin HCl)
Drug Information of Uroxatral
| Product NDC: | 24987-200 |
| Proprietary Name: | Uroxatral |
| Non Proprietary Name: | alfuzosin HCl |
| Active Ingredient(s): | 10 mg/1 & nbsp; alfuzosin HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Uroxatral
| Product NDC: | 24987-200 |
| Labeler Name: | Covis Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021287 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130603 |
Package Information of Uroxatral
| Package NDC: | 24987-200-20 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24987-200-20) |
NDC Information of Uroxatral
| NDC Code | 24987-200-20 |
| Proprietary Name | Uroxatral |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24987-200-20) |
| Product NDC | 24987-200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alfuzosin HCl |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130603 |
| Marketing Category Name | NDA |
| Labeler Name | Covis Pharmaceuticals Inc. |
| Substance Name | ALFUZOSIN HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
